BACOM2.0 facilitates absolute normalization and quantification of somatic copy number alterations in heterogeneous tumor

Scientific Reports
Yi FuYue Wang

Abstract

Most published copy number datasets on solid tumors were obtained from specimens comprised of mixed cell populations, for which the varying tumor-stroma proportions are unknown or unreported. The inability to correct for signal mixing represents a major limitation on the use of these datasets for subsequent analyses, such as discerning deletion types or detecting driver aberrations. We describe the BACOM2.0 method with enhanced accuracy and functionality to normalize copy number signals, detect deletion types, estimate tumor purity, quantify true copy numbers, and calculate average-ploidy value. While BACOM has been validated and used with promising results, subsequent BACOM analysis of the TCGA ovarian cancer dataset found that the estimated average tumor purity was lower than expected. In this report, we first show that this lowered estimate of tumor purity is the combined result of imprecise signal normalization and parameter estimation. Then, we describe effective allele-specific absolute normalization and quantification methods that can enhance BACOM applications in many biological contexts while in the presence of various confounders. Finally, we discuss the advantages of BACOM in relation to alternative approaches. Here ...Continue Reading

References

Jun 26, 2001·IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society·Y WangZ Szabo
Apr 9, 2002·IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society·Yue WangRobert Clarke
Mar 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kuan-Ting KuoTian-Li Wang
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peter Van LooVessela N Kristensen
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
May 1, 2012·Nature Biotechnology·Scott L CarterGad Getz
Jul 12, 2012·Nature Biotechnology·Peter Van Loo, Peter J Campbell
Aug 7, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HuijbersW E Mesker
Aug 28, 2012·Journal of the National Cancer Institute·Elisabetta KuhnIe-Ming Shih
Oct 27, 2012·Science Translational Medicine·Yinyin YuanFlorian Markowetz
Jul 31, 2013·Genome Biology·Layla OesperBenjamin J Raphael
Oct 12, 2013·Nature Communications·Kosuke YoshiharaRoel G W Verhaak
Feb 5, 2014·Genome Biology·Andrew FeberStephan Beck
Mar 19, 2014·DNA Repair·Lisa WoodbinePenny A Jeggo

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Software Mentioned

BACOM
R
Bioconductor
ABSOLUTE
bacomR
UNDO
BACOM2
ESTIMATE

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.